| For: | Murakami T, Imamura M, Kimura Y, Watanabe K, Shinohara Y, Nakamura T, Low SK, Motoya M, Kawakami Y, Masaki Y, Kubo T, Yoshida M, Yoshida E, Kato T, Kukita K, Kyuno D, Takemasa I. Role of preoperative circulating tumor DNA in predicting occult metastases in resectable and borderline resectable pancreatic ductal adenocarcinoma. World J Gastroenterol 2025; 31(32): 109383 [PMID: 40900777 DOI: 10.3748/wjg.v31.i32.109383] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i32/109383.htm |
| Number | Citing Articles |
| 1 |
Hao Liang, Ya-Kun Wu. Limited benefits of neoadjuvant therapy on R0 resection rate and overall survival in patients with resectable or locally advanced PDAC in randomized controlled trials. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1718537
|
| 2 |
Daniel Croagh, Saeed Aslani. Evidence Mapping of ctDNA Reporting in Pancreatic Ductal Adenocarcinoma: Toward a Shared Quantitative Language for ctDNA. Cancers 2026; 18(8) doi: 10.3390/cancers18081318
|
| 3 |
Maria Latiano, Maria De Angelis, Anna Latiano, Orazio Palmieri, Tiziana Pia Latiano, Marco Donatello Delcuratolo, Matteo Tardio, Francesca Bazzocchi, Marco Gentile, Fulvia Terracciano, Grazia Anna Niro, Francesca Tavano. Liquid Biopsy Frontiers in Pancreatic Cancer: Insights from Circulating Cell-Free Nucleic Acids. Cells 2026; 15(10) doi: 10.3390/cells15100904
|